FDA panel to focus on safety of Novartis gene therapy drug … – Business Insider
Business Insider |
FDA panel to focus on safety of Novartis gene therapy drug …
Business Insider (Reuters) – The U.S. Food and Drug Administration will ask a panel of advisors to focus on the safety of Novartis AG's experimental gene therapy drug when it … Novartis' CAR-T Therapy for Pediatric Leukemia to Face FDA Advisory Panel |
